ガイドライン

(旧版)科学的根拠に基づく
膵癌診療ガイドライン 2006年版

書誌情報
 
CQ1 診断法


CQ1-1 膵癌の危険因子は何か?

【引用文献】
1) DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999; 117: 1464-1484.
2) Gullo L, Pessilli R, Morselli-Labate AM. Coffee and cancer of the pancreas: an Italian multicenter study. The Italian Pancreatic Cancer Study Group. Pancreas 1995; 11: 223-229.
3) 日本膵臓学会膵癌登録委員会.膵癌全国登録調査報告.膵臓 2001; 16: 115-147.
4) 江川新一,武田和憲,福山尚治,阿部 永,横山忠明,砂村真琴,松野正紀.膵癌登録からみた膵癌のリスクファクター.肝胆膵 2004; 48: 547-554.
5) Whitcomb DC, Applebaum S, Martin SP. Hereditary pancreatitis and pancreatic carcinoma. Ann NY Acad Sci 1999; 880: 201-209.
6) Lynch HT, Brand RE, Lynch JF, Fusaro RM, Kern SE. Hereditary factors in pancreatic cancer. J Hepatobiliary Pancreat Surg 2002; 9: 12-31.
7) 北川元二.膵癌のリスクファクター 慢性膵炎.肝胆膵 2004; 48: 591-597.
8) Whitcomb DC, Pogue-Geile K. Pancreatitis as a risk for pancreatic cancer. Gastroenterol Clin North Am 2002; 31: 663-678.
9) Lowenfels AB, Maisonneuve P. Epidemiologic and etiologic factors of pancreatic cancer. Haematol Oncol Clin North Am 2002; 16: 1-16.
10) 林 櫻松,玉腰暁子.生活習慣と膵癌.肝胆膵2004; 48: 561-566.
11) Nishi M, Ohba S, Hirata K, Miyake H. Dose-response relationship between coffee and the risk of pancreas cancer. Jpn J Clin Oncol 1996; 26: 42-48.
12) de Vos tot Nederveen Cappel WH, Lagendijk MA, Lamers CB, Morreau H, Vasen HF. Surveillance for familial pancreatic cancer. Scand J Gastroenterol 2003; 239: 94-99.
13) Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, Perez-Perez G, Taylor PR, Virtamo J, Albanes D; ATBC Study. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Nat Cancer Inst 2001; 93: 937-941.


 

書誌情報